Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 998002

The impact of combined use of opioids, antipsychotics, and anxiolytics on survival in the hospice setting


Golčić, Marin; Dobrila-Dintinjana, Renata; Golčić, Goran; Čubranić, Aleksandar
The impact of combined use of opioids, antipsychotics, and anxiolytics on survival in the hospice setting // Journal of pain and symptom management, 55 (2018), 1; 22-30 doi:10.1016/j.jpainsymman.2017.08.004 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 998002 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
The impact of combined use of opioids, antipsychotics, and anxiolytics on survival in the hospice setting

Autori
Golčić, Marin ; Dobrila-Dintinjana, Renata ; Golčić, Goran ; Čubranić, Aleksandar

Izvornik
Journal of pain and symptom management (0885-3924) 55 (2018), 1; 22-30

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
antipsychotics ; anxiolytics ; hospice ; opioids ; palliative care ; survival ; ill cancer-patients ; end-of-life ; palliative care ; sedatives ; haloperidol ; association ; population ; overdose ; risk ; pain

Sažetak
Opioids and sedatives are the cornerstone of symptom management in the end- of-life patients, but undertreatment is a common problem. Although several studies explored the individual effect of opioids, anxiolytics, and antipsychotics on survival, not much is known regarding their combined use. As these drugs share similar and potentially fatal side effects, primarily respiratory depression which occurs more often during night-hours, it is crucial to explore whether their interaction poses a danger for fragile hospice patients. Objectives. To analyze the relationship of a combination of opioids, anxiolytics, and antipsychotics on survival and the change of night-time death percentage. Methods. A retrospective study of 765 consecutive patients admitted to hospice in Croatia over the period of four years (2013- 2017). The main outcome was the total length of survival of hospice patients regarding different drug combination, along with night- time death percentage. Results. Different combinations of opioids, anxiolytics, and antipsychotics were associated with longer survival in hospice compared with patients using no such drugs. When we included different parameters which affected overall survival into a multivariate analysis, only the patients who had the combination of both opioids, anxiolytics, and antipsychotics in their regular therapy were associated with longer survival in hospice (11 vs. five days, hazard ratio 0.54, P < 0.001). No combination of opioids, anxiolytics, and antipsychotics significantly changed the night-time death percentage. Conclusion. This research supports the safety of opioids, anxiolytics, and antipsychotics in the hospice setting when used both individually as well as in combination.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com

Citiraj ovu publikaciju:

Golčić, Marin; Dobrila-Dintinjana, Renata; Golčić, Goran; Čubranić, Aleksandar
The impact of combined use of opioids, antipsychotics, and anxiolytics on survival in the hospice setting // Journal of pain and symptom management, 55 (2018), 1; 22-30 doi:10.1016/j.jpainsymman.2017.08.004 (međunarodna recenzija, članak, znanstveni)
Golčić, M., Dobrila-Dintinjana, R., Golčić, G. & Čubranić, A. (2018) The impact of combined use of opioids, antipsychotics, and anxiolytics on survival in the hospice setting. Journal of pain and symptom management, 55 (1), 22-30 doi:10.1016/j.jpainsymman.2017.08.004.
@article{article, author = {Gol\v{c}i\'{c}, Marin and Dobrila-Dintinjana, Renata and Gol\v{c}i\'{c}, Goran and \v{C}ubrani\'{c}, Aleksandar}, year = {2018}, pages = {22-30}, DOI = {10.1016/j.jpainsymman.2017.08.004}, keywords = {antipsychotics, anxiolytics, hospice, opioids, palliative care, survival, ill cancer-patients, end-of-life, palliative care, sedatives, haloperidol, association, population, overdose, risk, pain}, journal = {Journal of pain and symptom management}, doi = {10.1016/j.jpainsymman.2017.08.004}, volume = {55}, number = {1}, issn = {0885-3924}, title = {The impact of combined use of opioids, antipsychotics, and anxiolytics on survival in the hospice setting}, keyword = {antipsychotics, anxiolytics, hospice, opioids, palliative care, survival, ill cancer-patients, end-of-life, palliative care, sedatives, haloperidol, association, population, overdose, risk, pain} }
@article{article, author = {Gol\v{c}i\'{c}, Marin and Dobrila-Dintinjana, Renata and Gol\v{c}i\'{c}, Goran and \v{C}ubrani\'{c}, Aleksandar}, year = {2018}, pages = {22-30}, DOI = {10.1016/j.jpainsymman.2017.08.004}, keywords = {antipsychotics, anxiolytics, hospice, opioids, palliative care, survival, ill cancer-patients, end-of-life, palliative care, sedatives, haloperidol, association, population, overdose, risk, pain}, journal = {Journal of pain and symptom management}, doi = {10.1016/j.jpainsymman.2017.08.004}, volume = {55}, number = {1}, issn = {0885-3924}, title = {The impact of combined use of opioids, antipsychotics, and anxiolytics on survival in the hospice setting}, keyword = {antipsychotics, anxiolytics, hospice, opioids, palliative care, survival, ill cancer-patients, end-of-life, palliative care, sedatives, haloperidol, association, population, overdose, risk, pain} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font